Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Global Biologics and Biosimilars Sales Market Revenue Status and Forecast to 2022

QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

This press release was orginally distributed by SBWire

City of Industry, CA -- (SBWIRE) -- 06/13/2018 -- This report studies the global Biologics and Biosimilars market status and forecast, categorizes the global Biologics and Biosimilars market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/158831/global-biologics-and-biosimilars-sales-market

Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.

Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The global Biologics and Biosimilars market is valued at 144700 million US$ in 2017 and will reach 220300 million US$ by the end of 2025, growing at a CAGR of 5.4% during 2018-2025.

The major players covered in this report

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Others

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

United States

Europe

China

Japan

Southeast Asia

India

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/158831/global-biologics-and-biosimilars-sales-market

About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.

For more information on this press release visit: http://www.sbwire.com/press-releases/global-biologics-and-biosimilars-sales-market-revenue-status-and-forecast-to-2022-994356.htm

Media Relations Contact

Rahul Singh
Director - Digital Marketing
QY Research, Inc
Telephone: 1-626-295-2442
Email: Click to Email Rahul Singh
Web: https://www.qyresearch.com/index/detail/158831/global-biologics-and-biosimilars-sales-market

Latest News
Top News